AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 43 filers reported holding AIM IMMUNOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6 | -100.0% | 18,191 | -38.0% | 0.00% | – |
| Q3 2022 | $17,000 | +21.4% | 29,352 | +125.2% | 0.00% | – |
| Q1 2022 | $14,000 | +16.7% | 13,033 | +0.5% | 0.00% | – |
| Q4 2021 | $12,000 | -89.1% | 12,970 | -76.1% | 0.00% | – |
| Q3 2021 | $110,000 | +189.5% | 54,376 | +206.9% | 0.00% | – |
| Q3 2020 | $38,000 | -92.4% | 17,715 | -90.9% | 0.00% | -100.0% |
| Q1 2020 | $498,000 | – | 194,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |